Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 69 Records) |
| Query Trace: Carcinoma and BAP1[original query] |
|---|
| Clonal architectures predict clinical outcome in clear cell renal cell carcinoma. Nature communications 2019 03 10 (1): 1245. Huang Yi, Wang Jiayin, Jia Peilin, Li Xiangchun, Pei Guangsheng, Wang Changxi, Fang Xiaodong, Zhao Zhongming, Cai Zhiming, Yi Xin, Wu Song, Zhang Baife |
| BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA. Journal of hepatology 2019 Dec . Hirsch Théo Z, Negulescu Ana, Gupta Barkha, Caruso Stefano, Noblet Bénédicte, Couchy Gabrielle, Bayard Quentin, Meunier Léa, Morcrette Guillaume, Scoazec Jean-Yves, Blanc Jean-Frédéric, Amaddeo Giuliana, Nault Jean-Charles, Bioulac-Sage Paulette, Ziol Marianne, Beaufrère Aurélie, Paradis Valérie, Calderaro Julien, Imbeaud Sandrine, Zucman-Rossi Jessi |
| Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations. Endocrine pathology 2019 11 30 (4): 276-284. Maffeis Valeria, Cappellesso Rocco, Nicolè Lorenzo, Guzzardo Vincenza, Menin Chiara, Elefanti Lisa, Schiavi Francesca, Guido Maria, Fassina Ambrog |
| Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
| Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population. BMC urology 2020 Aug 20 (1): 125. Suh Jungyo, Jeong Chang Wook, Choi Seongmin, Ku Ja Hyeon, Kim Hyeon Hoe, Kim Kwangsoo, Kwak Che |
| Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus. Nature communications 2020 2 11 (1): 739. Wang Xiang-Ming, Lu Yang, Song Yi-Meng, Dong Jun, Li Ruo-Yan, Wang Guo-Liang, Wang Xu, Zhang Shu-Dong, Dong Zhou-Huan, Lu Min, Wang Shi-Yu, Ge Li-Yuan, Luo Guang-Da, Ma Run-Zhuo, George Rozen Steve, Bai Fan, Wu Di, Ma Lu-L |
| Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings. Cancer 2020 Feb . Maynard Hannah, Stadler Zsofia K, Berger Michael F, Solit David B, Ly Michele, Lowery Maeve A, Mandelker Diana, Zhang Liying, Jordan Emmett, El Dika Imane, Kemel Yelena, Ladanyi Marc, Robson Mark E, O'Reilly Eileen M, Abou-Alfa Ghassan |
| Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma. Clinical genitourinary cancer 2020 Jan . Bacon Jack V W, Annala Matti, Soleimani Maryam, Lavoie Jean-Michel, So Alan, Gleave Martin E, Fazli Ladan, Wang Gang, Chi Kim N, Kollmannsberger Christian K, Wyatt Alexander W, Nappi Luc |
| 8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness. BMC urology 2020 10 20 (1): 173. Eckel-Passow Jeanette E, Yan Huihuang, Kosel Matthew L, Serie Daniel, Decker Paul A, Jenkins Robert B, Costello Brian, Leibovich Bradley, Ho Thai H, Parker Alexand |
| Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma. BioMed research international 2020 2020 2495157. Meng Hui, Jiang Xuewen, Cui Jianfeng, Yin Gang, Shi Benkang, Liu Qi, Xuan He, Wang |
| Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. Urologic oncology 2021 9 39 (11): 791.e17-791.e24. Mano Roy, Duzgol Cihan, Ganat Maz, Goldman Debra A, Blum Kyle A, Silagy Andrew W, Walasek Aleksandra, Sanchez Alejandro, DiNatale Renzo G, Marcon Julian, Kashan Mahyar, Becerra Maria F, Benfante Nicole E, Coleman Jonathan A, Kattan Michael W, Russo Paul, Akin Oguz, Ostrovnaya Irina, Hakimi A A |
| Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma. Cancers 2021 5 13 (9): . Moore Ariane L, Batavia Aashil A, Kuipers Jack, Singer Jochen, Burcklen Elodie, Schraml Peter, Beisel Christian, Moch Holger, Beerenwinkel Ni |
| Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma. Aging 2021 4 13 (7): 9960-9975. Zeng Hao, Chen Linyan, Wang Manni, Luo Yuling, Huang Yeqian, Ma Xuel |
| The spectrum of tumors harboring BAP1 gene alterations. Cancer genetics 2021 4 256-257 31-35. Laitman Yael, Newberg Justin, Molho Rinat Bernstein, Jin Dexter X, Friedman Eit |
| A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis. iScience 2021 3 24 (3): 102173. Niersch Jennifer, Vega-Rubín-de-Celis Silvia, Bazarna Anna, Mergener Svenja, Jendrossek Verena, Siveke Jens T, Peña-Llopis Samu |
| Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia. JAMA network open 2021 11 4 (11): e2132615. Gupta Sounak, Erickson Lori A, Lohse Christine M, Shen Wei, Pitel Beth A, Knight Shannon M, Halling Kevin C, Herrera-Hernandez Loren, Boorjian Stephen A, Thompson R Houston, Leibovich Bradley C, Jimenez Rafael E, Cheville John |
| Germ Line BAP1 Mutation in Patients with Uveal Melanoma and Renal Cell Carcinoma. Ocular oncology and pathology 2021 11 7 (5): 340-345. Shao Yusra F, DeBenedictis Meghan, Yeaney Gabrielle, Singh Arun |
| Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification. Cancer science 2021 10 113 (1): 297-307. Yoshikawa Yoshie, Yamada Yusuke, Emi Mitsuru, Atanesyan Lilit, Smout Jan, de Groot Karel, Savola Suvi, Nakanishi-Shinkai Yukako, Kanematsu Akihiro, Nojima Michio, Ohmuraya Masaki, Hashimoto-Tamaoki Tomoko, Yamamoto Shin |
| Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma. Translational andrology and urology 2020 Dec 9 (6): 2751-2763. Bi Hai, Yin Jipeng, Zhou Lang, Wu Yaqian, Ge Liyuan, Lu Min, Liu Lei, Zhang Hongxian, Zhao Yongzhe, Liu Cheng, Ma Lul |
| Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma. Frontiers in immunology 2022 7 13 925618. Zhang Zhen, Zeng Xiangyang, Wu Yinghua, Liu Yang, Zhang Xi, Song Zew |
| Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls. Human molecular genetics 2022 6 31 (12): 1962-1969. Sekine Yuya, Iwasaki Yusuke, Aoi Tomomi, Endo Mikiko, Hirata Makoto, Kamatani Yoichiro, Matsuda Koichi, Sugano Kokichi, Yoshida Teruhiko, Murakami Yoshinori, Fukui Tomohiro, Akamatsu Shusuke, Ogawa Osamu, Nakagawa Hidewaki, Numakura Kazuyuki, Narita Shintaro, Habuchi Tomonori, Momozawa Yukihi |
| Expression Of Bap1 In Clear Cell Renal Cell Carcinoma. Journal of Ayub Medical College, Abbottabad : JAMC 2022 5 34 (2): 283-287. Fatima Arooj, Mushtaq Sajid, Loya Asif, Hassan Usman, Sheikh Umer Nis |
| Comparison of whole exome sequencing in circulating tumor cells of primitive and metastatic nasopharyngeal carcinoma. Translational cancer research 2022 2 9 (7): 4080-4092. Si Jinyuan, Huang Bo, Lan Guiping, Zhang Benjian, Wei Jiazhang, Deng Zhuoxia, Li Yiliang, Qin Ying, Li Bing, Lu Yan, Si Yongfe |
| Semantic Computed Tomography Features for Predicting BRCA1-associated Protein 1 and/or Tumor Protein p53 Gene Mutation Status in Clear Cell Renal Cell Carcinoma. International journal of radiation oncology, biology, physics 2022 12 . Wu Xiao-Hui, Zhu Jun-Ming, Lin Bo-Han, Qiu Qian-Ren-Shun, Ruan Zhong-Tian, Wei Yong, Xue Xue-Yi, Zheng Qing-Shui, Chen Shao-Hao, Xu Ni |
| Characteristics of genomic mutations and signaling pathway alterations in thymic epithelial tumors. Annals of translational medicine 2022 1 9 (22): 1659. Yang Weilin, Chen Sai, Cheng Xinxin, Xu Bo, Zeng Huilan, Zou Jianyong, Su Chunhua, Chen Zhengua |
| Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies. Journal of Cancer 2022 1 13 (1): 88-101. Yan Yu-Chuan, Meng Guang-Xiao, Ding Zi-Niu, Liu Yan-Feng, Chen Zhi-Qiang, Yan Lun-Jie, Yang Ya-Fei, Liu Hui, Yang Chun-Cheng, Dong Zhao-Ru, Hong Jian-Guo, Li T |
| Identification of Survival-Specific Genes in Clear Cell Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel. Journal of personalized medicine 2022 Jan 12 (1): . Hwang Jia, Kim Heeeun, Han Jinseon, Lee Jieun, Hong Sunghoo, Kim Saewoong, Yoon Sungjoo Kim, Choi Keonwoo, Yang Jihoon, Park Unsang, Kim Kwangjoong, Yim Kwangil, Kim Yuil, Choi Yeongj |
| BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials. Cancer immunology, immunotherapy : CII 2023 4 . Liu Kan, Huang Yan, Xu Yu, Wang Guoqiang, Cai Shangli, Zhang Xu, Shi Taopi |
| Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (1): 100042. Yoshuantari Naomi, Jeng Yung-Ming, Liau Jau-Yu, Lee Chia-Hsiang, Tsai Jia-Hu |
| Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan. Cancer biomarkers : section A of Disease markers 2023 2 . Masood Atika, Sarfaraz Rahat, Zaki Saima, Shami Amira, Khaliq Saba, Naseem Nad |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: